United States — Food and Drug Administration & Faruqi & Faruqi
6 shared events · Importance 3 · Last updated Apr 22, 2026
Live sentiment trends, interaction importance charts, and action volume tracking available on the
NewsDesk Dashboard
Business
United States — Food and Drug Administration: The United States — Food and Drug Administration extended the PDUFA date for Biohaven Pharmaceutical Holding Company's troriluzole new drug application and is planning an advisory committee meeting, which led to a significant drop in Biohaven Pharmaceutical Holding Company's stock price.
Faruqi & Faruqi: Faruqi & Faruqi is a national securities law firm that is investigating potential claims against Biohaven Pharmaceutical Holding Company and encouraging investors to join a class action lawsuit.
Jul 25, 2025 · 6 articles
Regulatory
Faruqi & Faruqi: Faruqi & Faruqi is a national securities law firm that is investigating potential claims against Unicycive Therapeutics, Inc. and encouraging investors to join a class action lawsuit.
Aug 22, 2025 · 6 articles
Business
Faruqi & Faruqi: Faruqi & Faruqi is a national securities law firm investigating potential claims against Telix Pharmaceuticals and encouraging investors to join the class action lawsuit.
Nov 20, 2025 · 6 articles
NEWSDESK
Explore this relationship live
Track how United States — Food and Drug Administration and Faruqi & Faruqi interact across events, view sentiment trends, and discover connected entities.
Open Dashboard